Bio-Rad’s 2023 Financial Results Announced Today, Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a prominent figure in life science research and clinical diagnostics, unveiled its financial results for the fourth…
Forecast for Global Retinal Surgery Device Markets (2022-2030) – Company Profiles, Major Deals, Strategies, and Recent Developments The report on the Global Retinal Surgery Devices Market, including Device Segments, Applications,…
Armis , the asset intelligence cybersecurity company, today announced it has been named “Top Performer” in the 2024 Best in KLAS Software & Services Report for Healthcare IoT Security for the second year in…
Today, Revvity, Inc. (NYSE: RVTY) has unveiled the Signals ClinicalTM solution through its software and informatics division, Revvity Signals. This groundbreaking software-as-a-service (SaaS) platform is designed to revolutionize clinical trial…
For the fifth year running, MEDITECH’s Expanse platform maintains its dominant position at the forefront of the KLAS leaderboard. In the 2024 Best in KLAS: Software & Services report, Expanse…
The ResearchAndMarkets.com platform now includes the “Fetal Doppler Market – Global Outlook & Forecast 2023-2028” report in its offerings. The global fetal Doppler market is poised for significant advancement driven…
Data from the inaugural US-wide single-center experience at St. Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session during the AF Symposium 2024 in Boston, demonstrates that…
Edwards Lifesciences Corporation (NYSE: EW) has announced the FDA approval of its EVOQUE tricuspid valve replacement system, marking a groundbreaking achievement as the first transcatheter therapy authorized for treating tricuspid…
Solidsoft Reply, a subsidiary of the Reply Group specializing in crafting business solutions on the Microsoft Azure cloud, has successfully migrated Finland’s National Medicines Verification System to its National Blueprint…
Kindeva Drug Delivery (Kindeva), a prominent player in drug and medical device combination products globally, has unveiled the expansion of its analytical services, establishing a new global business unit. This…
-GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions to the global healthcare market, We announced that our implant, PERLE™, was recently featured in an…
GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, is proud to announce that its PERLE™ breast implant is featured in…